Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Clinical Neuropharmacology|January 12, 2001
Myotoxicity and neurotoxicity during clozapine treatmentI Reznik, L Volchek, R Mester, et al.Comprehensive Psychiatry|September 1, 1995
A new approach to affective symptoms in relapsing-remitting multiple sclerosisS Noy, A Achiron, U Gabbay, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1991
The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjectsM Glikson, A Achiron, Z Ram, et al.Clinical and Experimental Immunology|May 1, 1996
Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of actionA Achiron, Y Barak, M Goren, et al.The Journal of Pediatrics|September 1, 1993
Hereditary motor-sensory neuropathy (Charcot-Marie-Tooth disease) with nerve deafness: a new variantO P Hamiel, A Raas-Rothschild, M Upadhyaya, et al.Archives of Neurology|December 1, 1992
Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosisA Achiron, E Pras, R Gilad, et al.Neurology|March 4, 1998
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapsesA Achiron, U Gabbay, R Gilad, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1994
Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of actionA Achiron, R Gilad, R Margalit, et al.Clinical Immunology (Orlando, Fla.)|September 29, 2004
T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patientsA Achiron, G Lavie, I Kishner, et al.Neoplasma|March 15, 2019
ASXL1 gene alterations in patients with isolated 20q deletionJ Brezinova, I Sarova, K Svobodova, et al.Pageof 6